Abstract.
Rupture of membranes before 37 completed weeks of gestation, and before the onset of contractions occurs among 2–3% of pregnancies, and in about 30%–40% of women who deliver preterm. It is known as preterm premature rupture of membranes (PPROM) and is associated with maternal and neonatal morbidity. It has been postulated that antibiotic therapy may significantly decrease the complications associated with infection. The aim of the present review is to summarize the available data about the value of antibiotic therapy in PPROM.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 18 November 1997 / Accepted: 29 December 1997
Rights and permissions
About this article
Cite this article
Maymon, E., Chaim, W., Sheiner, E. et al. A review of randomized clinical trials of antibiotic therapy in preterm premature rupture of the membranes. Arch Gynecol Obstet 261, 173–181 (1998). https://doi.org/10.1007/s004040050218
Issue Date:
DOI: https://doi.org/10.1007/s004040050218